SG151253A1 - Combination vaccines with low dose of hib conjugate - Google Patents
Combination vaccines with low dose of hib conjugateInfo
- Publication number
- SG151253A1 SG151253A1 SG200901653-6A SG2009016536A SG151253A1 SG 151253 A1 SG151253 A1 SG 151253A1 SG 2009016536 A SG2009016536 A SG 2009016536A SG 151253 A1 SG151253 A1 SG 151253A1
- Authority
- SG
- Singapore
- Prior art keywords
- hib
- vaccines
- conjugate
- low dose
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0405787.3A GB0405787D0 (en) | 2004-03-15 | 2004-03-15 | Low dose vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
SG151253A1 true SG151253A1 (en) | 2009-04-30 |
Family
ID=32117706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200901653-6A SG151253A1 (en) | 2004-03-15 | 2005-03-14 | Combination vaccines with low dose of hib conjugate |
Country Status (13)
Country | Link |
---|---|
US (2) | US20090208526A1 (ru) |
EP (1) | EP1725258B1 (ru) |
JP (2) | JP4954056B2 (ru) |
CN (2) | CN102028944B (ru) |
AT (1) | ATE480257T1 (ru) |
BR (1) | BRPI0508813B8 (ru) |
CA (1) | CA2559996C (ru) |
DE (1) | DE602005023422D1 (ru) |
DK (1) | DK1725258T3 (ru) |
GB (1) | GB0405787D0 (ru) |
RU (1) | RU2435609C2 (ru) |
SG (1) | SG151253A1 (ru) |
WO (1) | WO2005089794A2 (ru) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1296715T4 (en) * | 2000-06-29 | 2016-03-07 | Smithkline Beecham Biolog | Multivalent vaccine composition. |
GB0505518D0 (en) * | 2005-03-17 | 2005-04-27 | Chiron Srl | Combination vaccines with whole cell pertussis antigen |
DK2878307T3 (da) | 2005-06-27 | 2019-10-07 | Glaxosmithkline Biologicals Sa | Immunogen sammensætning |
DK2066344T3 (da) | 2006-09-07 | 2011-09-05 | Glaxosmithkline Biolog Sa | Inaktiveret Poliovirus kombinationsvaccine |
GB0700135D0 (en) * | 2007-01-04 | 2007-02-14 | Glaxosmithkline Biolog Sa | Vaccine |
CA2688268A1 (en) * | 2007-06-04 | 2008-12-11 | Novartis Ag | Formulation of meningitis vaccines |
CU23652A1 (es) * | 2007-06-29 | 2011-05-27 | Centro Inmunologia Molecular | Composición vacunal homogénea para el tratamiento del cáncer y su método de obtención |
WO2009133408A2 (en) | 2008-05-01 | 2009-11-05 | Arecor Limited | Protein formulation |
PE20100366A1 (es) | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion |
PE20100365A1 (es) | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion |
GB0822633D0 (en) * | 2008-12-11 | 2009-01-21 | Novartis Ag | Formulation |
US9950062B2 (en) | 2009-09-02 | 2018-04-24 | Glaxosmithkline Biologicals Sa | Compounds and compositions as TLR activity modulators |
CN102655879B (zh) * | 2009-12-16 | 2016-03-09 | 印度血清研究所 | 疫苗组合物 |
BR112013005134A2 (pt) | 2010-09-01 | 2018-04-24 | Novartis Ag | adsorção de imunopotenciadores em sais metálicos insolúveis |
US20140112950A1 (en) * | 2011-03-02 | 2014-04-24 | Manmohan Singh | Combination vaccines with lower doses of antigen and/or adjuvant |
EP2699266B1 (en) * | 2011-04-21 | 2019-06-12 | Trustees Of Tufts College | Compositions and methods for stabilization of active agents |
CN104159602B (zh) | 2012-03-08 | 2017-10-24 | 葛兰素史密丝克莱恩生物有限公司 | 加强疫苗的含佐剂制剂 |
MX2015005444A (es) * | 2012-10-29 | 2015-07-17 | Univ Arkansas | Nuevos coadyuvantes y sistemas de administracion para mucosas. |
RU2626532C2 (ru) * | 2015-01-16 | 2017-07-28 | Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации | Комбинированная вакцина для профилактики коклюша, дифтерии, столбняка, гепатита в и инфекции, вызываемой haemophilus influenzae тип в |
EP3530285B1 (en) * | 2016-10-20 | 2023-08-09 | KM Biologics Co., Ltd. | METHOD FOR PRODUCING HIB CONJUGATE VACCINE USING PRP WITH
LOWERED MOLECULAR WEIGHT |
BR112020000999A2 (pt) | 2017-07-18 | 2020-07-14 | Serum Institute Of India Pvt Ltd. | composição imunogênica tendo estabilidade aperfeiçoada, imunogenicidade melhorada e reatogenicidade reduzida e processo para a sua preparação |
CN110251667A (zh) * | 2018-05-11 | 2019-09-20 | 武汉博沃生物科技有限公司 | 一种免疫组合制剂及其制备方法和应用 |
JOP20190242A1 (ar) | 2018-10-12 | 2020-04-12 | Serum Institute Of India Pvt Ltd | تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها |
WO2021176409A1 (en) | 2020-03-05 | 2021-09-10 | Sanofi Healthcare India Private Limited | Preservative combination for vaccine composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2734484B1 (fr) * | 1995-05-24 | 1997-06-27 | Pasteur Merieux Serums Vacc | Composition vaccinale liquide et procede de fabrication |
US20020054884A1 (en) * | 1995-06-23 | 2002-05-09 | Smithkline Beecham Biologicals, Sa | Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
DK1082965T3 (da) * | 1995-06-23 | 2009-07-27 | Glaxosmithkline Biolog Sa | Et vaccinepræparat der omfatter et polysaccharidkonjugatantigen adsorberet på aluminiumphosphat |
DK1296715T4 (en) * | 2000-06-29 | 2016-03-07 | Smithkline Beecham Biolog | Multivalent vaccine composition. |
-
2004
- 2004-03-15 GB GBGB0405787.3A patent/GB0405787D0/en not_active Ceased
-
2005
- 2005-03-14 SG SG200901653-6A patent/SG151253A1/en unknown
- 2005-03-14 CN CN2010105870900A patent/CN102028944B/zh not_active Expired - Fee Related
- 2005-03-14 DK DK05727218.9T patent/DK1725258T3/da active
- 2005-03-14 CN CN2005800152906A patent/CN1968711B/zh not_active Expired - Fee Related
- 2005-03-14 US US10/593,007 patent/US20090208526A1/en not_active Abandoned
- 2005-03-14 WO PCT/IB2005/000927 patent/WO2005089794A2/en active Application Filing
- 2005-03-14 BR BRPI0508813A patent/BRPI0508813B8/pt active IP Right Grant
- 2005-03-14 EP EP05727218A patent/EP1725258B1/en active Active
- 2005-03-14 DE DE602005023422T patent/DE602005023422D1/de active Active
- 2005-03-14 RU RU2006136212/15A patent/RU2435609C2/ru not_active IP Right Cessation
- 2005-03-14 AT AT05727218T patent/ATE480257T1/de not_active IP Right Cessation
- 2005-03-14 CA CA2559996A patent/CA2559996C/en not_active Expired - Fee Related
- 2005-03-14 JP JP2007503444A patent/JP4954056B2/ja not_active Expired - Fee Related
-
2008
- 2008-03-06 JP JP2008056997A patent/JP2008150397A/ja active Pending
-
2011
- 2011-09-30 US US13/250,094 patent/US9259460B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2007529503A (ja) | 2007-10-25 |
US20090208526A1 (en) | 2009-08-20 |
CN1968711A (zh) | 2007-05-23 |
US9259460B2 (en) | 2016-02-16 |
CN102028944B (zh) | 2013-12-04 |
RU2435609C2 (ru) | 2011-12-10 |
DK1725258T3 (da) | 2010-11-01 |
BRPI0508813B8 (pt) | 2021-05-25 |
BRPI0508813B1 (pt) | 2019-05-21 |
CA2559996A1 (en) | 2005-09-29 |
RU2006136212A (ru) | 2008-04-27 |
CN1968711B (zh) | 2011-01-05 |
US20120107346A1 (en) | 2012-05-03 |
EP1725258B1 (en) | 2010-09-08 |
CA2559996C (en) | 2014-08-05 |
DE602005023422D1 (de) | 2010-10-21 |
WO2005089794A2 (en) | 2005-09-29 |
BRPI0508813A (pt) | 2007-08-07 |
CN102028944A (zh) | 2011-04-27 |
EP1725258A2 (en) | 2006-11-29 |
JP2008150397A (ja) | 2008-07-03 |
ATE480257T1 (de) | 2010-09-15 |
GB0405787D0 (en) | 2004-04-21 |
WO2005089794A3 (en) | 2006-03-09 |
JP4954056B2 (ja) | 2012-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG151253A1 (en) | Combination vaccines with low dose of hib conjugate | |
ES2164251T5 (es) | Vacuna que comprende un conjugado antigeno polisacarido-proteina transportadora y proteina transportadora libre. | |
SI1835939T1 (sl) | Cepljenje na osnovi meningokoknih konjugatov | |
UY26801A1 (es) | Composición de vacuna | |
EP3170508A1 (en) | Vaccine formulations | |
NZ598367A (en) | Multiple vaccination including serogroup C meningococcus | |
PT1740217E (pt) | Vacinação meningocócica conjugada | |
HK1074578A1 (en) | Packaged virus-like particles in combination with cpg for use as adjuvants with allergens: method of preparation and use | |
MX2008013993A (es) | Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular. | |
JP2015531389A5 (ru) | ||
RU2015106745A (ru) | Иммуногенные композиции | |
WO2013171661A2 (en) | Adjuvant formulations and methods | |
IL107387A (en) | Combination pediatric vaccine with enhanced immunogenicity of each vaccine component | |
Wu et al. | Development of pneumococcal polysaccharide conjugate vaccine with long spacer arm | |
ES2365557T5 (es) | Vacunas de combinación de Poliovirus inactivado | |
WO2002004497A3 (en) | Multiple antigenic peptides immunogenic against streptococcus pneumoniae | |
Carson et al. | Reimmunization after stem cell transplantation | |
SA96170157B1 (ar) | تركيب لقاح composition vaccine يشتمل على مولد مضاد متعدد سكريد مقترن antigen conjugated polsaccharide يتم امتزازه على فوسفات الألومنيوم aluminum phosphate | |
MXPA97009732A (en) | Vaccine comprising a conjugate of antigen depolisacarido protein carrier and protein carrier li |